ReviewJournal of public health in Africa2025
Prevalence and causes of vision impairment in East Africa: A narrative review.
Review in Journal of public health in Africa, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Parents' perception of common childhood eye diseases: a community-based cross-sectional study.BMC ophthalmology · 2026Article
- Prevalence of vision impairment in Rwanda: a hospital-based study.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vision impairment (VI) affects the quality of life of individuals; it negatively impacts education, mobility and socioeconomic life, leading to dependency. Increased life expectancy is expected to drive a corresponding rise in the prevalence of VI. Timely and effective efforts are required to reduce the burden of VI. Accurate and up-to-date data regarding the prevalence and causes of VI are essential for practical planning to address its challenges and impact. This review therefore presents the prevalence of VI in East Africa. Aim: This review sought to report the prevalence of VI in East Africa. Setting: The study was conducted using findings of studies on VI from East Africa. Method: A search of published literature was conducted using online databases including PubMed, Ovid, Science Direct, Google Scholar, Embase and Medline. The search was restricted to sources published in English and in peer-reviewed journals from January 2010 to November 2023. Only studies that stated the prevalence and causes of VI among the general population during the period in question were included. Results: Twenty nine studies met the inclusion criteria and were included in this review. The prevalence of VI reported in East Africa by the studies reviewed ranged from 1.6% to 42.1%. Conclusion: The reported prevalence of VI in East Africa is higher than that reported in other regions of Africa and globally. Contribution: The review highlights the need for adequate strategies and support to be channelled towards making eye care accessible and affordable in East Africa including the training of more eye health personnel.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.